Caroline Tillett - Mar 5, 2025 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Chief Scientific Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Stock symbol
KVUE
Transactions as of
Mar 5, 2025
Transactions value $
-$35,228
Form type
4
Date filed
3/7/2025, 05:03 PM
Previous filing
Feb 18, 2025
Next filing
Mar 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVUE Common Stock Options Exercise $0 +4.27K +10.31% $0.00 45.7K Mar 5, 2025 Direct F1
transaction KVUE Common Stock Tax liability -$35.2K -1.53K -3.35% $23.04 44.1K Mar 5, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Options Exercise $0 -4.27K -33.34% $0.00 8.53K Mar 5, 2025 Common Stock 4.27K Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These units correspond 1 for 1 with the Company's common stock.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units (RSUs).
F3 This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date.
F4 Includes RSUs acquired as dividend equivalents.